Abbott GmbH & Co. KG

Industry / private company


Location: Wiesbaden, Germany (DE) DE

ISNI: 0000000405356583

ROR: https://ror.org/02x2gk324

Show on Map:

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Absorb® bioresorbable scaffold in “established” versus “off-label” coronary lesions: 5-year data from the GABI-R® registry (2025) Huseynov A, Behnes M, Nef H, Riemer T, Schneider S, Pfannebecker T, Achenbach S, et al. Journal article Reduction of inappropriate implantable cardioverter-defibrillator therapies using enhanced supraventricular tachycardia discriminators: the ReduceIT study. (2021) Geller JC, Woehrle A, Busch M, Elsaesser A, Kleemann T, Birkenhauer F, Bramlage P, Veltmann C Journal article Results of Multicenter Evaluation of Plug Use for LVAD Explantation (2021) Potapov E, Politis N, Rieger S, Karck M, Weyand M, Walther T, Emrich F, et al. Conference contribution Comparison between treatment of “established” versus complex “off-label” coronary lesions with Absorb® bioresorbable scaffold implantation: results from the GABI-R® registry (2019) Huseynov A, Baumann S, Nef H, Riemer T, Schneider S, Pfannenbecker T, Achenbach S, et al. Journal article Predictors of early scaffold thrombosis: results from the multicenter prospective German-Austrian ABSORB RegIstRy (2018) Woehrle J, Nef HM, Naber C, Achenbach S, Riemer T, Mehilli J, Muenzel T, et al. Journal article Evaluation of the short- and long-term safety and therapy outcomes of the everolimus-eluting bioresorbable vascular scaffold system in patients with coronary artery stenosis: Rationale and design of the German-Austrian ABSORB RegIstRy (GABI-R) (2016) Nef H, Wiebe J, Achenbach S, Muenzel T, Naber C, Richardt G, Mehilli J, et al. Journal article